Atypical glandular cells (AGC): ThinPrep imaging system (TIS), manual screening (MS), and correlation with Hybrid Capture 2 (HC2) HPV DNA testing

2009 ◽  
pp. n/a-n/a
Author(s):  
Anthony N. Sireci ◽  
John P. Crapanzano ◽  
Mahesh Mansukhani ◽  
Thomas Wright ◽  
Anamaria Babiac ◽  
...  
Keyword(s):  
Imaging System ◽  
Dna Testing ◽  
Hybrid Capture ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2 ◽  
Glandular Cells ◽  
Atypical Glandular Cells

Three-Year Follow-up for Women 30 Years and Older with Negative Pap and Negative Hybrid Capture 2 HPV DNA Testing Results

2012 ◽  
Vol 1 (1) ◽  
pp. S40
Author(s):  
Marilyn Dawlett ◽  
Teresa Kologinczak ◽  
Jian-Ping Wang ◽  
Nour Sneige ◽  
Therese Bevers ◽  
...  
Keyword(s):  
Dna Testing ◽  
Hybrid Capture ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2

Risk of CIN2+ in Women 30 Years and Older with Negative Pap and Positive Hybrid Capture 2 HPV DNA Testing Results

2012 ◽  
Vol 1 (1) ◽  
pp. S52
Author(s):  
Jian-Ping Wang ◽  
Teresa Kologinczak ◽  
Marilyn Dawlett ◽  
Therese Bevers ◽  
Nour Sneige ◽  
...  
Keyword(s):  
Dna Testing ◽  
Hybrid Capture ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2

scholarly journals Characteristics of Apparently False-Negative Digene Hybrid Capture 2 High-Risk HPV DNA Testing

2006 ◽  
Vol 125 (2) ◽  
pp. 223-228 ◽  
Author(s):  
Raid Jastania ◽  
William R. Geddie ◽  
William Chapman ◽  
Scott Boerner
Keyword(s):  
High Risk ◽  
False Negative ◽  
Dna Testing ◽  
Hybrid Capture ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2 ◽  
High Risk Hpv

scholarly journals Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

2005 ◽  
Vol 124 (5) ◽  
pp. 716-721 ◽  
Author(s):  
Francesca Maria Carozzi ◽  
Annarosa Del Mistro ◽  
Massimo Confortini ◽  
Cristina Sani ◽  
Donella Puliti ◽  
...  
Keyword(s):  
Dna Testing ◽  
Hybrid Capture ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2

scholarly journals Clinical Prediction Based on HPV DNA Testing by Hybrid Capture 2 (HC2) in Combination with Liquid-based Cytology (LBC)

2013 ◽  
Vol 14 (2) ◽  
pp. 903-907 ◽  
Author(s):  
Pairoj Junyangdikul ◽  
Watcharaporn Tanchotsrinon ◽  
Jira Chansaenroj ◽  
Pornjarim Nilyaimit ◽  
Chidchanok Lursinsap ◽  
...  
Keyword(s):  
Clinical Prediction ◽  
Dna Testing ◽  
Hybrid Capture ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2 ◽  
Liquid Based Cytology

scholarly journals Performance of HPV DNA Testing with Hybrid Capture 2 in Triaging Women with Minor Cervical Cytologic Abnormalities (ASC-US/LSIL) in Northern Thailand

2015 ◽  
Vol 15 (24) ◽  
pp. 10961-10966 ◽  
Author(s):  
Surapan Khunamornpong ◽  
Jongkolnee Settakorn ◽  
Kornkanok Sukpan ◽  
Jatupol Srisomboon ◽  
Prapaporn Suprasert ◽  
...  
Keyword(s):  
Dna Testing ◽  
Northern Thailand ◽  
Hybrid Capture ◽  
Hpv Dna ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2 ◽  
Cytologic Abnormalities

Human Papillomavirus DNA Testing as an Adjunct to Cytology in Cervical Screening Programs

2003 ◽  
Vol 127 (8) ◽  
pp. 959-968 ◽  
Author(s):  
Attila T. Lörincz ◽  
Ralph M. Richart
Keyword(s):  
High Grade ◽  
Dna Testing ◽  
Papanicolaou Test ◽  
Chain Reaction ◽  
Hpv Dna ◽  
Screening Programs ◽  
Hpv Dna Testing ◽  
Hybrid Capture 2 ◽  
Screening Intervals ◽  
Polymerase Chain

Abstract Our objective was to review current large studies of human papillomavirus (HPV) DNA testing as an adjunct to the Papanicolaou test for cervical cancer screening programs. We analyzed 10 large screening studies that used the Hybrid Capture 2 test and 3 studies that used the polymerase chain reaction test in a manner that enabled reliable estimates of accuracy for detecting or predicting high-grade cervical intraepithelial neoplasia (CIN). Most studies allowed comparison of HPV DNA and Papanicolaou testing and estimates of the performance of Papanicolaou and HPV DNA as combined tests. The studies were selected on the basis of a sufficient number of cases of high-grade CIN and cancer to provide meaningful statistical values. Investigators had to demonstrate the ability to generate reasonably reliable Hybrid Capture 2 or polymerase chain reaction data that were either minimally biased by nature of study design or that permitted analytical techniques for addressing issues of study bias to be applied. Studies had to provide data for the calculation of test sensitivity, specificity, predictive values, odds ratios, relative risks, confidence intervals, and other relevant measures. Final data were abstracted directly from published articles or estimated from descriptive statistics presented in the articles. In some studies, new analyses were performed from raw data supplied by the principal investigators. We concluded that HPV DNA testing was a more sensitive indicator for prevalent high-grade CIN than either conventional or liquid cytology. A combination of HPV DNA and Papanicolaou testing had almost 100% sensitivity and negative predictive value. The specificity of the combined tests was slightly lower than the specificity of the Papanicolaou test alone, but this decrease could potentially be offset by greater protection from neoplastic progression and cost savings available from extended screening intervals. One “double-negative” HPV DNA and Papanicolaou test indicated better prognostic assurance against risk of future CIN 3 than 3 subsequent negative conventional Papanicolaou tests and may safely allow 3-year screening intervals for such low-risk women.

Sign in / Sign up

Export Citation Format

Share Document